BullishAgent BullishAgent
EDGAR Earnings Ratings Insiders Shorts
ETFs Screener Research
Sign in Register
EDGAR SEC Filings Guide ↗ · Our AI agent reads every SEC filing so you don't have to — one sentence, zero noise.
| |
2026-07-02 125 new filings · 🔴 42 very high 🟡 46 high 🟢 37 medium 🎯 3 acquisitions 👤 36 exec changes 🤝 5 deals ⚠️ 1 auditor change

Latest 100 — Business partnerships

!! High 8-K · 1.01 Distribution Deal $2.0M #103414 · Jul 2
iPower Inc. -- 8-K 1.01: Distribution Agreement

Supplement to Supply and Distribution Agreement As previously disclosed in its Current Report on Form 8-K filed on February 2, 2026, on February 1, 2026, iPower Inc, a Nevada corporation ( iPower or the Company ), entered into a supply and distribution agreement (the SDA ) with its formerly-wholly owned subsidiary, Global Product Marketing, Inc., a Nevada corporation ( GPM ), and its 100% stockholder, ETTS AI Investment LLC, a Nevada limited liability company ( ETTS AI ). On June 30, 2026, the C

!!! Very High 8-K · 1.01 Merger Agreement $809.7K #100810 · Jun 30
NON INVASIVE MONITORING SYSTEMS INC /FL/ -- 8-K 1.01: Merger Agreement

On June 30, 2026 , Non-Invasive Monitoring Systems, Inc. (the Amendment ) to (i) extend the Outside Termination Date (as defined in the Agreement and Plan of Merger and Reorganization) dated March 6, 2026 (the Agreement )), (ii) provide for certain resale registration rights for a holder of a convertible note and (iii) revise certain of the closing conditions set forth in Sections 5.1 and 5.3 of the Agreement.

!!! Very High 8-K · 1.01 Merger Agreement $112 #99179 · Jun 29
Iridium Communications Inc. -- 8-K 1.01: Merger Agreement

Entered into Agreement and Plan of Merger with Rocket Lab Corp.

Iridium Communications agreed to merge with Rocket Lab in an all-stock transaction, combining satellite communications with launch services capabilities and creating an integrated space infrastructure provider.

!!! Very High 8-K · 1.01 Merger Agreement $112 #99190 · Jun 29
Rocket Lab USA, Inc. -- 8-K 1.01: Merger Agreement

Entered into Agreement and Plan of Merger with Iridium Communications Inc.

Rocket Lab (RKLB) agreed to merge with Iridium Communications (IRDM), combining the satellite communications companies and creating a larger competitor in the space technology sector.

!! High 8-K · 1.01 Distribution Deal $1 #99149 · Jun 29
Honeywell Aerospace Inc. -- 8-K 1.01: Distribution Agreement

Entered into Trademark License Agreement with Honeywell, inc.

Honeywell Aerospace Inc. established a Trademark License Agreement with parent company Honeywell International, allowing the aerospace division to utilize Honeywell's brand assets for its operations and products.

!!! Very High 8-K · 1.01 Merger Agreement $96 #89473 · Jun 15
Roku, Inc. -- 8-K 1.01: Merger Agreement

Entered into Agreement and Plan of Merger.

Fox Corporation agreed to acquire Roku in an all-stock deal, combining Fox's media distribution with Roku's streaming platform to strengthen competitive positioning against Netflix and Amazon.

!!! Very High 8-K · 1.01 Merger Agreement #87515 · Jun 11
Adial Pharmaceuticals, Inc. -- 8-K 1.01: Merger Agreement

Immediately following the First Merger, Azora merged with and into Second Merger Sub, pursuant to which Second Merger Sub was the surviving entity and a wholly owned subsidiary of the Company (together with the First Merger, the Merger ). The Merger is intended to qualify as a tax-free reorganization for U.S.

!!! Very High 8-K · 1.01 Merger Agreement $1.5M #83550 · Jun 9
Lisata Therapeutics, Inc. -- 8-K 1.01: Merger Agreement

(the Company or Lisata ) and Kuva Labs Inc., a Delaware corporation ( Parent ), together with Kuva Acquisition Corp., a Delaware corporation and a wholly owned subsidiary of Parent ( Purchaser ), entered into an amendment and waiver (the Amendment ) to the previously announced Agreement and Plan of Merger, dated as of March 6, 2026, by and among Parent, Purchaser and the Company (as it may be amended from time to time, the Merger Agreement ). The Amendment also extended the Outside Date (as defi

!!! Very High 8-K · 1.01 Merger Agreement #84717 · Jun 9
VerifyMe, Inc. -- 8-K 1.01: Merger Agreement

On June 4, 2026, the Parties entered into the Second Amendment (the Amendment ) to the Merger Agreement, pursuant to which the definition of Fully Diluted Company Shares was revised to include the aggregate number of Open World ordinary shares issuable in connection with any existing agreement to issue Equity Interests (as such term is defined in the Merger Agreement) of Open World. The foregoing description of the Amendment does not purport to be complete and subject to, and is qualified in its

!! High 8-K · 1.01 License Deal $500.0M #79252 · Jun 3
Mineralys Therapeutics, Inc. -- 8-K 1.01: License Agreement

Fourth Amendment to the License Agreement On June 2, 2026, Mineralys Therapeutics, Inc. Under the Amendment, the license granted by Tanabe to the Company related to lorundrostat was amended and restated to grant to the Company an exclusive, worldwide, royalty-free, sublicensable, perpetual and irrevocable license to the licensed intellectual property, and the Company will no longer have any diligence obligations to Tanabe with respect to the ongoing development or commercialization of lorundrost

!! High 8-K · 1.01 Supply Agreement $5.0M #79421 · Jun 3
Mainz Biomed N.V. -- 8-K 1.01: Supply Agreement

( BP United ), which amends that certain Intellectual Property License Agreement, dated as of May 12, 2026, between the Company and BP United (the IP Agreement ). The Original Agreement contemplated that the parties would enter into an Exclusive Supply Agreement (the Supply Agreement ) to facilitate the transactions contemplated by the Original Agreement.

!! High 8-K · 1.01 Collaboration $500.0K #74606 · May 27
Aptevo Therapeutics Inc. -- 8-K 1.01: Collaboration Agreement

Collaboration Agreement and Supply Agreement with Niowave On May 25, 2026, Aptevo Research and Development LLC ( Aptevo Research ), a subsidiary of Aptevo Therapeutics Inc. ( Niowave ) entered into a collaboration agreement (the Collaboration Agreement ) to collaborate on the development of a potential human therapeutic product incorporating Aptevo s proprietary molecules (including APVO455) and Niowave s proprietary radioisotopes (including Actinium-225).

!! High 8-K · 1.01 License Deal $125.0K #72258 · May 26
Aspira Women's Health Inc -- 8-K 1.01: License Agreement

Entered into Master Collaboration and License Agreement.

Aspira Women's Health secured a Master Collaboration and License Agreement, potentially expanding its product portfolio and revenue streams through partnerships or technology access.

!! High 8-K · 1.01 Distribution Deal $2.0B #68206 · May 19
Capital Southwest Corporation -- 8-K 1.01: Distribution Agreement

Agreement with Raymond James Associates, Inc. $2.0 billion.

Capital Southwest Corporation expanded its distribution capacity by establishing a $2.0 billion agreement with Raymond James Associates, significantly enhancing its ability to raise capital for investments.

!! High 8-K · 1.01 Distribution Deal $2.7B #64463 · May 14
CEL-SCI Corporation -- 8-K 1.01: Distribution Agreement

On May 11,2026 , the Company issued a press release, filed as Exhibit 99, concerning a strategic partnership, distribution, and revenue sharing agreement with Amarox for regulatory affairs, marketing and potential commercialization of Multikine (Leukocyte Interleukin, Injection) in the treatment of head and neck cancer in Saudi Arabia, with an optional extension for the Gulf Cooperation Council (GCC) countries including Bahrain, Kuwait, Oman, Qatar, and the United Arab Emirates.

!!! Very High 8-K · 1.01 Merger Agreement $95.0M #61848 · May 13
Assertio Holdings, Inc. -- 8-K 1.01: Merger Agreement

Entered into Agreement and Plan of Merger with Garda Therapeutics, Inc.

Assertio Holdings agreed to merge with Garda Therapeutics, combining the two specialty pharmaceutical companies into a single entity to enhance market position and operational efficiency.

!! High 8-K · 1.01 Distribution Deal #55280 · May 6
Oxford Square Capital Corp. -- 8-K 1.01: Distribution Agreement

The Amended Equity Distribution Agreement allows for sales pursuant to the Amended Equity Distribution Agreement to continue under the Company s currently effective shelf registration statement. The offering is being made pursuant to the Company s effective shelf registration statement on Form N-2 (Registration No.

Oxford Square Capital Corp. renewed its equity distribution agreement, enabling continued at-the-market share sales under its existing shelf registration to raise capital efficiently without repeated SEC filings.

!!! Very High 8-K · 1.01 Merger Agreement $1.1M #52614 · May 4
Lisata Therapeutics, Inc. -- 8-K 1.01: Merger Agreement

(the Company or Lisata ) and Kuva Labs Inc., a Delaware corporation ( Parent ), together with Kuva Acquisition Corp., a Delaware corporation and a wholly owned subsidiary of Parent ( Purchaser ), entered into an amendment and waiver (the Amendment and Waiver ) to the previously announced Agreement and Plan of Merger, dated as of March 6, 2026, by and among Parent, Purchaser and the Company (the Merger Agreement ). Under the Amendment and Waiver, Parent has also agreed to pay certain expenses of

Lisata Therapeutics amended its merger agreement with Kuva Labs, with Kuva agreeing to cover additional company expenses, modifying terms of the previously announced acquisition deal.

!!! Very High 8-K · 1.01 Merger Agreement $25 #52631 · May 4
Modiv Inc. -- 8-K 1.01: Merger Agreement

Entered into Agreement and Plan of Merger with Global Net Lease, Inc.

Modiv Inc. agreed to merge with Global Net Lease, Inc., combining the two net lease REITs in a significant consolidation that will create a larger real estate investment entity.

!!! Very High 8-K · 1.01 Merger Agreement $11.0M #52649 · May 4
Apimeds Pharmaceuticals US, Inc -- 8-K 1.01: Merger Agreement

Entered into Confidential Settlement and Mutual Release Agreement with Inscobee Inc.

Apimeds Pharmaceuticals (APUS) settled disputes with Inscobee Inc. under confidential terms, resolving mutual claims through a release agreement that eliminates legal liabilities for both parties.

!!! Very High 8-K · 1.01 Merger Agreement $95.0M #52737 · May 4
Assertio Holdings, Inc. -- 8-K 1.01: Merger Agreement

Entered into Amended and Restated Agreement and Plan of Merger with Garda Therapeutics, Inc.

Assertio Holdings agreed to merge with Garda Therapeutics under an amended merger agreement, potentially consolidating the two pharmaceutical companies and reshaping Assertio's corporate structure.

!!! Very High 8-K · 1.01 Merger Agreement $80.0M #51105 · Apr 28
RE/MAX HOLDINGS, INC. -- 8-K 1.01: Merger Agreement

Entered into Arrangement Agreement and Plan of Merger with Parent, inc. $60 million.

RE/MAX Holdings agreed to be acquired by Parent Inc. for $60 million, representing a significant transaction that will result in the company being taken private.

!! High 8-K · 1.01 Distribution Deal #51024 · Apr 28
Dynex Capital, Inc. -- 8-K 1.01: Distribution Agreement

LLC ( Goldman Sachs ), JonesTrading Institutional Services LLC, J.P. Morgan Securities LLC, Keefe, Bruyette Woods, Inc., Morgan Stanley Co.

Dynex Capital engaged Goldman Sachs, Morgan Stanley, J.P. Morgan, and other major financial institutions as underwriters for a securities distribution, likely facilitating capital raising through a coordinated offering process.

!!! Very High 8-K · 1.01 Merger Agreement $3.0M #40912 · Apr 24
Peoples Bancorp Inc/OH -- 8-K 1.01: Merger Agreement

Entered into Agreement and Plan of Merger.

Peoples Bancorp Inc (PEBO) has agreed to merge with Fiserv subsidiary, creating a combined entity that will strengthen both companies' financial services capabilities and market position.

!! High 8-K · 1.01 Collaboration $35.0M #39212 · Apr 21
Wellgistics Health, Inc. -- 8-K 1.01: Collaboration Agreement

Entered into Collaboration Agreement with Kare Rx Hub, LLC.

Wellgistics Health entered a collaboration agreement with Kare Rx Hub, LLC, potentially expanding its pharmaceutical distribution and healthcare services capabilities through strategic partnership.

!!! Very High 8-K · 1.01 Merger Agreement #39133 · Apr 20
USA Rare Earth, Inc. -- 8-K 1.01: Merger Agreement

The Merger Agreement, the Form of Voting Agreement, and the Form of Registration Rights Agreement relating to the transactions contemplated by the Merger Agreement (the Transactions ) are included as Exhibits 2.1, 10.1 and 10.2 hereto, respectively, and are incorporated herein by reference. The material terms of the Merger Agreement, the Voting Agreement, and the Registration Rights Agreement were previously described in USAR s Current Report on Form 8-K filed on April 20, 2026, which descriptio

USA Rare Earth (USAR) has filed merger agreement documentation with voting and registration rights agreements, completing disclosure of previously announced transaction terms from April 2026.

!! High 8-K · 1.01 Collaboration #38977 · Apr 20
High Roller Technologies, Inc. -- 8-K 1.01: Collaboration Agreement

Entered into Mutual Collaboration Agreement with Foris DAX Markets, Inc.

High Roller Technologies (ROLR) entered into a mutual collaboration agreement with Foris DAX Markets, expanding its business partnerships and potentially opening new revenue opportunities through the combined expertise of both companies.

!! High 8-K · 1.01 Collaboration $2.0M #20122 · Apr 17
Wellgistics Health, Inc. -- 8-K 1.01: Collaboration Agreement

Entered into Collaboration Agreement with Kare Rx Hub, LLC.

Wellgistics Health (WGRX) has established a collaboration agreement with Kare Rx Hub, LLC, potentially expanding its pharmaceutical distribution and healthcare service capabilities through this partnership.

!!! Very High 8-K · 1.01 Merger Agreement #20192 · Apr 16
Unknown — 8-K 1.01: Merger Agreement

orld, Ltd., (incorporated herein by reference from Exhibit 2.2 to the Company s Registration Statement on Form S-4, filed on April 15, 2026). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

VRME announced a merger agreement, signaling potential significant operational changes and shareholder dilution or cash considerations that will reshape the company's business structure and investor value.

!!! Very High 8-K · 1.01 Merger Agreement #20665 · Apr 13
Unknown — 8-K 1.01: Merger Agreement

Entered into each of the Supplemental Indentures following receipt of the requisite con with Madison Parent Inc.

Comcast's supplemental indentures with Madison Parent suggest debt restructuring ahead of a potential merger, which could dilute existing shareholders or increase financial leverage.

!!! Very High 8-K · 1.01 Merger Agreement $20 #20881 · Apr 10
Unknown — 8-K 1.01: Merger Agreement

r Common Stock), each right entitling the holder thereof to receive one-tenth (1/10) of a share of Acquirer Common Stock upon the consummation of an initial business combination; and (D) to provide that either the Company or the Acquiror has the right to terminate the Merger Agreement if either party has made a written request of the other party pursuant to the Merger Agreement and five Business Days have passed, and the requesting party has not received a response. The foregoing summary of the

FGMC announced a merger agreement with termination rights after five business days without response, meaning shareholders face execution risk and potential deal collapse if negotiations stall.

!!! Very High 8-K · 1.01 Merger Agreement $20 #20897 · Apr 10
Unknown — 8-K 1.01: Merger Agreement

quirer Common Stock upon the consummation of an initial business combination; and (D) to provide that either the Company or the Acquiror has the right to terminate the Merger Agreement if either party has made a written request of the other party pursuant to the Merger Agreement and five Business Days have passed, and the requesting party has not received a response. The foregoing summary of the Amendment does not purport to be complete and is qualified in its entirety by reference to the Amendm

FGMC's merger agreement was amended to include termination rights if either party fails to respond within five business days, reducing deal certainty and increasing risk that the combination fails.